The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect
dc.contributor.author | Rasmi, Yousef | |
dc.contributor.author | Jalali, Ladan | |
dc.contributor.author | Khalid, Saliha | |
dc.contributor.author | Shokati, Ameneh | |
dc.contributor.author | Tyagi, Poonam | |
dc.contributor.author | Ozturk, Alpaslan | |
dc.contributor.author | Nasimfar, Amir | |
dc.date.accessioned | 2023-10-19T15:11:32Z | |
dc.date.available | 2023-10-19T15:11:32Z | |
dc.date.issued | 2023 | |
dc.department-temp | [Rasmi, Yousef; Jalali, Ladan] Urmia Univ Med Sci, Fac Med, Dept Biochem, Orumiyeh, Iran; [Khalid, Saliha] Kadir Has Univ, Sch Engn & Nat Sci, Dept Bioinformat & Genet, Cibali Campus Fatih, TR-34083 Istanbul, Turkiye; [Shokati, Ameneh] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Appl Cell Sci, Tehran, Iran; [Shokati, Ameneh] Univ Tehran Med Sci, Neurosci Inst, Multiple Sclerosis Res Ctr, Tehran, Iran; [Tyagi, Poonam] Prince Sattam Bin Abdulaziz Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh, Saudi Arabia; [Ozturk, Alpaslan] Hlth Sci Univ, Ankara Diskapi Yildirim Beyazit Training & Res Hos, Dept Med Biochem, Ankara, Turkiye; [Nasimfar, Amir] Urmia Univ Med Sci, Fac Med, Dept Pediat, Orumiyeh, Iran; [Jalali, Ladan] Urmia Univ Med Sci, Sch Med, Dept Biochem, Orumiyeh, Iran | en_US |
dc.description.abstract | Prolactin (PRL) is an endocrine hormone secreted by the anterior pituitary gland that has a variety of physiological effects, including milk production, immune system regulation, and anti-inflammatory effects. Elevated levels of PRL have been found in several viral infections, including 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), a viral pathogen that has recently spread worldwide. PRL production is increased in SARS-CoV2 infection. While PRL can trigger the production of proinflammatory cytokines, it also has several anti-inflammatory effects that can reduce hyperinflammation. The exact mechanism of PRL's contribution to the severity of COVID-19 is unknown. The purpose of this review is to discuss the interaction between PRL and SARS-CoV2 infection and its possible association with the severity of COVID-19. | en_US |
dc.identifier.citation | 4 | |
dc.identifier.doi | 10.1016/j.cyto.2023.156253 | en_US |
dc.identifier.issn | 1043-4666 | |
dc.identifier.issn | 1096-0023 | |
dc.identifier.pmid | 37320963 | en_US |
dc.identifier.scopus | 2-s2.0-85162171729 | en_US |
dc.identifier.scopusquality | Q2 | |
dc.identifier.uri | https://doi.org/10.1016/j.cyto.2023.156253 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12469/5061 | |
dc.identifier.volume | 169 | en_US |
dc.identifier.wos | WOS:001054021200001 | en_US |
dc.identifier.wosquality | Q3 | |
dc.khas | 20231019-WoS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Academic Press Ltd- Elsevier Science Ltd | en_US |
dc.relation.ispartof | Cytokine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Necrosis-Factor-Alpha | En_Us |
dc.subject | Activated Macrophages | En_Us |
dc.subject | Signal-Transduction | En_Us |
dc.subject | Growth-Hormone | En_Us |
dc.subject | C-Jun | En_Us |
dc.subject | Expression | En_Us |
dc.subject | Cell | En_Us |
dc.subject | Receptor | En_Us |
dc.subject | Mechanisms | En_Us |
dc.subject | Release | En_Us |
dc.subject | Necrosis-Factor-Alpha | |
dc.subject | Activated Macrophages | |
dc.subject | Signal-Transduction | |
dc.subject | Growth-Hormone | |
dc.subject | C-Jun | |
dc.subject | Expression | |
dc.subject | Prolactin | en_US |
dc.subject | Cell | |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Receptor | |
dc.subject | Severity | en_US |
dc.subject | Mechanisms | |
dc.subject | COVID-19 | en_US |
dc.subject | Release | |
dc.subject | Immunomodulatory effects | en_US |
dc.title | The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |